Home » CME
CME Continuing Medical Education
ONCOLOGY Continuing Medical Education December 2009
This activity is based on review articles in the journal ONCOLOGY. It is developed from an identified educational need for information about practical management issues in the practice of medical, surgical, and radiation oncology. This activity has been developed and approved under the direction of CME LLC. More »
ONCOLOGY Continuing Medical Education November 2009 II
ONCOLOGY Continuing Medical Education November 15, 2009
This activity is based on review articles in the journal ONCOLOGY. It is developed from an identified educational need for information about practical management issues in the practice of medical, surgical, and radiation oncology. This activity has been developed and approved under the direction of CME LLC. More »
ONCOLOGY Continuing Medical Education September 2009
This activity is based on review articles in the journal ONCOLOGY. It is developed from an identified educational need for information about practical management issues in the practice of medical, surgical, and radiation oncology. This activity has been developed and approved under the direction of CME LLC. More »
ONCOLOGY Continuing Medical Education August 2009
This activity is based on review articles in the journal ONCOLOGY. It is developed from an identified educational need for information about practical management issues in the practice of medical, surgical, and radiation oncology. This activity has been developed and approved under the direction of CME LLC. More »
ONCOLOGY Continuing Medical Education July 2009
This activity is based on review articles in the journal ONCOLOGY. It is developed from an identified educational need for information about practical management issues in the practice of medical, surgical, and radiation oncology. This activity has been developed and approved under the direction of CME LLC. More »
ONCOLOGY Continuing Medical Education June 2009
This activity is based on review articles in the journal ONCOLOGY. It is developed from an identified educational need for information about practical management issues in the practice of medical, surgical, and radiation oncology. This activity has been developed and approved under the direction of CME LLC. More »
What Is the Optimal Initial Treatment of Low-Risk Papillary Thyroid Cancer (and Why Is It Controversial)?
Patients with papillary thyroid cancer typically undergo a triad of consecutive initial treatments, comprising surgery, radioiodine therapy, and thyroid hormone suppression of serum thyrotropin (thyroid-stimulating hormone, or TSH). More »
Low-Risk Papillary Thyroid Cancer: Treatment Options and Patient Perceptions
Differentiated thyroid cancer, the most common endocrine malignancy, can touch the lives of young and old individuals. It is generally associated with a normal lifespan whether it is completely eradicated or held in check with judicious medical interventions. More »
Can Risk-Adapted Treatment Recommendations Replace the ‘One Size Fits All’ Approach for Early-Stage Thyroid Cancer Patients?
There is uniform agreement that initial treatment of high-risk thyroid cancer should include total thyroidectomy, compartmental neck dissection of clinically involved cervical lymph nodes, and radioactive iodine (RAI) remnant ablation. More »
Showing 1 - 10 of 57 results.
Page of 6

CME LLC's Highlights in Breast Cancer Treatment From the ASCO® 2009 Annual Meeting

CME LLC's Highlights in Breast Cancer Treatment From the ASCO® 2009 Annual Meeting

 

 

Update #1

 

Update 1: Concept of Maintenance
Chemotherapy in NSCLC

Update 2: MSI - To Test or Not To Test

Update 3: MSI - The Role of Cetuximab in NSCLC
(Lancet-flex Study)

Update 4: New Studies in GI Cancer

Update 5: Patient Selection for Adjuvant Therapy

 

Tumor Board Events
On-Demand

In Streaming Video

 

Learn from thought leaders through interactive webcast discussions, designed to help you navigate treatment challenges in oncology.

 

New Perspectives in Metastatic Breast Cancer 2009
An Online Tumor Board Event
A Seidman

Hosted by:
Program Chair: Andrew D. Seidman, MD,
Professor of Medicine, Weill Medical College of Cornell University Attending Physician, Memorial Sloan-Kettering Cancer Center New York, NY

Renal Cell Carcinoma
An On-Demand Tumor Board Event

Hosted by:
Program Chair: Ronald M. Bukowski, MD,
Emeritus Staff, CCF Taussing Cancer Center Proffessor of Medicine, CCF Lerner College of Medicine of CWRU, Case Western


Chronic Myelogenous Leukemia
An On-Demand Tumor Board Event

Hosted by:
Program Chair: Charles A. Schiffer, MD,
Director, Multidisciplinary Leukemia Lymphoma Medical Oncology, Wayne State University School of Medicine, Detroit


Perspectives in Colorectal Cancer 2008
An On-Demand Tumor Board Event

Hosted by:
Program Chair John L. Marshall, MD
Chief, Division of Hematology and Oncology Lombardi Comprehensive Cancer Center Georgetown University

Explore these critical case reviews:

  • Frontline Metastatic Colorectal Cancer: Unresectable Liver Metastase
  • Frontline Metastatic Colorectal Cancer: Resectable Liver Metastases
  • Adjuvant Treatment for Colorectal Cancer: Stage II and Stage III
  • Refractory Colorectal Cancer

 

 

 

ONCOLOGY Issues

ONCOLOGY Nurse Edition

ONCOLOGY Nurse Edition Continuing Medical Education October 2009
ONCOLOGY Nurse Edition,  October 15, 2009
ONCOLOGY Nurse Edition Continuing Medical Education July 2009
ONCOLOGY Nurse Edition,  July 15, 2009
ONCOLOGY Nurse Edition Continuing Medical Education April 2009
ONCOLOGY Nurse Edition,  March 15, 2009
ONCOLOGY Nurse Edition Continuing Medical Education Feburary 2009
ONCOLOGY Nurse Edition,  February 15, 2009
ONCOLOGY Nurse Edition Continuing Education October 2008
ONCOLOGY Nurse Edition,  October 15, 2008